Transplacental traffic after in utero mesenchymal stem cell transplantation
- PMID: 20131967
- DOI: 10.1089/scd.2009.0434
Transplacental traffic after in utero mesenchymal stem cell transplantation
Abstract
Transplacental traffic of fetal progenitor and differentiated cells is a well-known phenomenon in pregnancies. We hypothesize that intrauterine stem cell transplantation leads to microchimerism in the dams and that this is gestational age-dependent. EGFP+ fetal liver-derived mesenchymal stem cell (MSC) (10(5) per fetus) were injected intraperitoneally into congeneic and allogeneic recipient fetuses at E12 versus E13.5 of murine pregnancy (56 dams). Engraftment in maternal organs was evaluated using TaqMan quantitative polymerase chain reaction (PCR) and fluorescence microscopy during pregnancy (1, 3, and 7 days after in utero transplantation [IUT]) and after delivery (1 and 4 weeks after delivery). One day after IUT donor cells were mainly found in the placenta (E12: 9/10 dams vs. E13.5: 4/8 dams) and laparotomy site (E12: 5/10 dams vs. E13.5: 4/8 dams). Three days after IUT these probabilities decreased significantly in the placenta to 3/8 and 1/3, respectively, whereas it was increased within the surgical wound to 8/8 and 2/4. One week after IUT donor cells could be detected in other single maternal organs, such as bone marrow or spleen. The surgical wound was chimeric in all dams. One week after delivery the surgical wound was still a major site of engraftment in both groups. E12 IUT resulted in detectable donor cell microchimerism in the maternal bone marrow (3/4), liver (2/4), lungs (1/4), spleen (1/4), and thymus (1/4), whereas engraftment probabilities were lower following E13.5 IUT (BM: 1/4, liver: 2/4, lungs: 1/4, spleen: 1/4, thymus: 0/4). At 4 weeks after delivery persistent microchimerism was found only after E12 IUT in various maternal organs (BM: 1/4, spleen: 1/4, lungs: 1/4) and within newly created surgical wounds (3/4), but completely not in the E13.5 group. Allogeneic IUT did also not result in any detectable long-term fetal microchimerism. An earlier IUT might lead to a higher transplacental traffic of donor MSC and persistent microchimerism within maternal tissues. Even 4 weeks after delivery, these cells are present in surgical wounds.
Similar articles
-
Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model.Transplantation. 2001 Dec 15;72(11):1768-76. doi: 10.1097/00007890-200112150-00010. Transplantation. 2001. PMID: 11740386
-
B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.Biol Blood Marrow Transplant. 2005 Sep;11(9):657-71. doi: 10.1016/j.bbmt.2005.05.012. Biol Blood Marrow Transplant. 2005. PMID: 16125636
-
Microchimerism and tolerance after in utero bone marrow transplantation in mice.J Surg Res. 1998 Jun;77(1):1-5. doi: 10.1006/jsre.1997.5255. J Surg Res. 1998. PMID: 9698523
-
Human fetal mesenchymal stem cells.Curr Stem Cell Res Ther. 2006 Sep;1(3):371-86. doi: 10.2174/157488806778226768. Curr Stem Cell Res Ther. 2006. PMID: 18220881 Review.
-
The Theoretical Basis of In Utero Hematopoietic Stem Cell Transplantation and Its Use in the Treatment of Blood Disorders.Stem Cells Dev. 2021 Jan 15;30(2):49-58. doi: 10.1089/scd.2020.0181. Stem Cells Dev. 2021. PMID: 33280478 Review.
Cited by
-
Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero.Congenit Anom (Kyoto). 2015 Feb;55(1):55-64. doi: 10.1111/cga.12099. Congenit Anom (Kyoto). 2015. PMID: 25421592 Free PMC article.
-
Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.Front Pharmacol. 2022 Sep 2;13:851375. doi: 10.3389/fphar.2022.851375. eCollection 2022. Front Pharmacol. 2022. PMID: 36120324 Free PMC article. Review.
-
The when, what, and where of naturally-acquired microchimerism.Semin Immunopathol. 2025 Mar 11;47(1):20. doi: 10.1007/s00281-024-01029-2. Semin Immunopathol. 2025. PMID: 40067465 Review.
-
Stem cells and neuroprotection: understanding the players.Int J Mol Sci. 2010 Sep 15;11(9):3288-97. doi: 10.3390/ijms11093288. Int J Mol Sci. 2010. PMID: 20957094 Free PMC article. Review.
-
High incidence of contaminating maternal cell overgrowth in human placental mesenchymal stem/stromal cell cultures: a systematic review.Stem Cells Transl Med. 2014 Nov;3(11):1305-11. doi: 10.5966/sctm.2014-0051. Epub 2014 Aug 25. Stem Cells Transl Med. 2014. PMID: 25154781 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources